Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis

Risk Factors for Cytomegalovirus Infection after Human Marrow Transplantation

1986 • 803 citations

Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation

1999 • 699 citations

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

2001 • 687 citations

Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant

1993 • 679 citations

Nonbacterial Pneumonia After Allogeneic Marrow Transplantation: A Review of Ten Years' Experience

1982 • 537 citations

Comparison of Immune Reconstitution After Unrelated and Related T-Cell–Depleted Bone Marrow Transplantation: Effect of Patient Age and Donor Leukocyte Infusions

1999 • 486 citations

Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation

1995 • 469 citations

Ganciclovir Prophylaxis of Cytomegalovirus Infection and Disease in Allogeneic Bone Marrow Transplant Recipients: Results of a Placebo-Controlled, Double-Blind Trial

1993 • 433 citations

Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell–depleted stem cell transplantation

2000 • 344 citations

Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation

1994 • 284 citations

Recovery of immune reactivity after T-cell–depleted bone marrow transplantation depends on thymic activity

2000 • 258 citations

Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation

1992 • 241 citations

IMMUNE DONORS CAN PROTECT MARROW-TRANSPLANT RECIPIENTS FROM SEVERE CYTOMEGALOVIRUS INFECTIONS

1987 • 236 citations

Recovery of immune reactivity after T-cell–depleted bone marrow transplantation depends on thymic activity

2000 • 231 citations

RESULTS OF DIFFERENT STRATEGIES FOR REDUCING CYTOMEGALOVIRUS-ASSOCIATED MORTALITY IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS1

1998 • 187 citations

Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease

1998 • 185 citations

Cytomegalovirus seropositivity adversely influences outcome after T‐depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft‐versus‐host disease prophylaxis

2001 • 108 citations

Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors

1997 • 85 citations

PROPHYLACTIC GANCICLOVIR TREATMENT REDUCES FUNGAL AS WELL AS CYTOMEGALOVIRUS INFECTIONS AFTER HEART TRANSPLANTATION1,2

1995 • 73 citations

Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation

2000 • 59 citations

REQUIREMENT OF RESIDUAL THYMUS TO RESTORE NORMAL T-CELL SUBSETS AFTER HUMAN ALLOGENEIC BONE MARROW TRANSPLANTATION1

2000 • 57 citations

CYTOMEGALOVIRUS INFECTION IN THE BONE MARROW TRANSPLANT RECIPIENT

1995 • 47 citations

CMV Infections following Allogeneic BMT: Risk Factors, Early Treatment and Correlation with Transplant-Related Mortality

1992 • 44 citations

Effect of Cytomegalovirus Infection on 1‐Year Mortality Rates Among Recipients of Allogeneic Bone Marrow Transplants

1998 • 22 citations